In humans, a relationship between intrauterine growth restriction (IUGR) and cardiac diseases, hypertension, type 2 diabetes, resistance to insulin, and obesity has been well documented, making evident the role of prenatal programming as a determinant of diseases in the adult [4-7]. The gene discussed is INS; the disease is fetal growth restriction.